Fig. 1
From: Uveal melanoma in the Iranian population: two decades of patient management in a tertiary eye center
Overall survival analysis. (A): Overall survival. Time: Time following primary treatment, months. (B): Overall survival by distance metastasis. Time: Time following primary treatment, months. (C): Overall survival by age. Time: Time following primary treatment, months. (D): Overall survival by tumor thickness. Time: Time following primary treatment, months. (E): Overall survival by tumor diameter. Time: Time following primary treatment, months. (F): Overall survival by primary treatment (Brachytherapy vs. Enucleation). Time: Time following primary treatment, months